Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2013, Article ID 340702, 8 pages
http://dx.doi.org/10.1155/2013/340702
Research Article

The Effect of Cotrimoxazole Prophylactic Treatment on Malaria, Birth Outcomes, and Postpartum CD4 Count in HIV-Infected Women

1University of North Carolina Gillings School of Global Public Health, 2104 McGavran-Greenberg Hall, 135 Dauer Drive, CB 7435, Chapel Hill, NC 27599-7435, USA
2UNC Project-Malawi, Tidziwe Centre, Private Bag A-104, Lilongwe, Malawi
3University of North Carolina Gillings School of Global Public Health, 3107-E McGavran-Greenberg Hall, Chapel Hill, NC 27599, USA
4University of North Carolina Gillings School of Global Public Health, 2104 McGavran-Greenberg Hall, Chapel Hill, NC 27599-7435, USA
5US Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
6The Ohio State University, N1145 Doan Hall, 410 W. 10th Avenue Columbus, OH 43210, USA
7Epidemiology and Biostatistics Division, School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
8Division of Infectious Diseases, University of North Carolina, 130 Mason Farm Road, Chapel Hill, NC 27599-7030, USA

Received 19 June 2013; Accepted 7 October 2013

Academic Editor: Ann Duerr

Copyright © 2013 Anna Dow et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Anglaret, G. Chêne, A. Attia et al., “Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial,” The Lancet, vol. 353, no. 9163, pp. 1463–1468, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Mermin, J. Lule, J. P. Ekwaru et al., “Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda,” The Lancet, vol. 364, no. 9443, pp. 1428–1434, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Campbell, D. Moore, R. Degerman et al., “HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea,” Clinical Infectious Diseases, vol. 54, no. 8, pp. 1204–1211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Lowrance, S. Makombe, A. Harries et al., “Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi,” Journal of Acquired Immune Deficiency Syndromes, vol. 46, no. 1, pp. 56–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Z. Wiktor, M. Sassan-Morokro, A. D. Grant et al., “Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial,” The Lancet, vol. 353, no. 9163, p. 1469, 1999. View at Google Scholar · View at Scopus
  6. WHO, “Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings,” Geneva, Switzerland, 2006.
  7. J. Walter, M. Mwiya, N. Scott et al., “Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts,” Journal of Infectious Diseases, vol. 194, no. 11, pp. 1510–1518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Mermin, J. P. Ekwaru, C. A. Liechty et al., “Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study,” The Lancet, vol. 367, no. 9518, pp. 1256–1261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. F. O. ter Kuile, M. E. Parise, F. H. Verhoeff et al., “The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 2, pp. 41–54, 2004. View at Google Scholar · View at Scopus
  10. A. Kapito-Tembo, S. R. Meshnick, M. B. Van Hensbroek, K. Phiri, M. Fitzgerald, and V. Mwapasa, “Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi,” Journal of Infectious Diseases, vol. 203, no. 4, pp. 464–472, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. van der Horst, C. Chasela, Y. Ahmed et al., “Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi,” Contemporary Clinical Trials, vol. 30, no. 1, pp. 24–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. S. Chasela, M. G. Hudgens, D. J. Jamieson et al., “Maternal or infant antiretroviral drugs to reduce HIV-1 transmission,” The New England Journal of Medicine, vol. 362, no. 24, pp. 2271–2281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. World Health Organization, “Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings,” Geneva, Switzerland, 2006.
  14. National Statistical Office (NSO) and ICF Macro, “Malawi demographic and health survey 2010,” Zomba, Malawi and Calverton, MD: NSO and ICF Macro, 2011.
  15. J. Gutman, D. Mwandama, R. E. Wiegand, D. Ali, D. P. Mathanga, and J. Skarbinski, “Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in machinga district, Malawi,” The Journal of Infectious Diseases, vol. 208, pp. 907–916, 2013. View at Google Scholar
  16. M. E. Stokes, C. S. Davis, and G. G. Koch, Categorical Data Analysis Using the SAS System, SAS Institute, Cary, NC, USA, 2nd edition, 2000.
  17. P. D. Allison, Survival Analysis Using SAS, SAS Institute, Cary, NC, USA, 1995.
  18. K. J. Rothman and S. Greenland, Modern Epidemiology, Lippincott-Raven, Philadelphia, Pa, USA, 1998.
  19. G. Maldonado and S. Greenland, “Simulation study of confounder-selection strategies,” American Journal of Epidemiology, vol. 138, no. 11, pp. 923–936, 1993. View at Google Scholar · View at Scopus
  20. L.-A. McNutt, C. Wu, X. Xue, and J. P. Hafner, “Estimating the relative risk in cohort studies and clinical trials of common outcomes,” American Journal of Epidemiology, vol. 157, no. 10, pp. 940–943, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kutner, C. Nachtsheim, J. Neter, and W. Li, Applied Linear Statistical Models, McGraw-Hill Irwin, New York, NY, USA, 5th edition, 2005.
  22. J. Mermin, J. Lule, J. P. Ekwaru et al., “Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members,” AIDS, vol. 19, no. 10, pp. 1035–1042, 2005. View at Google Scholar · View at Scopus
  23. C. Chintu, G. J. Bhat, A. S. Walker et al., “Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial,” The Lancet, vol. 364, no. 9448, pp. 1865–1871, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Nunn, P. Mwaba, C. Chintu, A. Mwinga, J. H. Darbyshire, and A. Zumla, “Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial,” BMJ, vol. 337, p. a257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Watera, J. Todd, R. Muwonge et al., “Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 3, pp. 373–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Thera, P. S. Sehdev, D. Coulibaly et al., “Impact of trimethoprim-sulfemethoxazole prophylaxis on falciparum malaria infection and disease,” Journal of Infectious Diseases, vol. 192, no. 10, pp. 1823–1829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-L. Newell, C. Rudin, D. Dunn, and C. Peckham, “Immunological markers in HIV-infected pregnant women,” AIDS, vol. 11, no. 15, pp. 1859–1865, 1997. View at Google Scholar · View at Scopus
  28. D. K. Ekouevi, A. Inwoley, B. Tonwe-Gold et al., “Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings,” AIDS Research and Human Retroviruses, vol. 23, no. 12, pp. 1469–1473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Watera, J. Todd, G. Mutonyi et al., “Effects of cotrimoxazole on hematologic parameters in HIV-infected adults in a community-based clinic in entebbe, Uganda,” Journal of Acquired Immune Deficiency Syndromes, vol. 46, no. 3, pp. 369–371, 2007. View at Publisher · View at Google Scholar · View at Scopus